Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Nicole Germino is an analyst at Truist Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/02/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
04/07/2025 | CATX | Buy Now | Perspective Therapeutics | — | — | Nicole Germino43% | $21 → $10 | Maintains | Buy | Get Alert |
03/05/2025 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.11 | 337.96% | Nicole Germino43% | $21 → $18 | Maintains | Buy | Get Alert |
02/21/2025 | INSM | Buy Now | Insmed | $72.64 | 48.68% | Nicole Germino43% | $105 → $108 | Maintains | Buy | Get Alert |
01/23/2025 | SGMO | Buy Now | Sangamo Therapeutics | $0.76 | 554.45% | Nicole Germino43% | $7 → $5 | Maintains | Buy | Get Alert |
11/01/2024 | INSM | Buy Now | Insmed | $72.64 | 44.55% | Nicole Germino43% | $100 → $105 | Reiterates | Buy → Buy | Get Alert |
10/11/2024 | INSM | Buy Now | Insmed | $72.64 | 37.67% | Nicole Germino43% | $85 → $100 | Maintains | Buy | Get Alert |
09/25/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | Nicole Germino43% | → $21 | Initiates | → Buy | Get Alert |
08/12/2024 | INSM | Buy Now | Insmed | $72.64 | 17.02% | Nicole Germino43% | $88 → $85 | Maintains | Buy | Get Alert |
07/01/2024 | INSM | Buy Now | Insmed | $72.64 | 21.15% | Nicole Germino43% | $68 → $88 | Maintains | Buy | Get Alert |
06/28/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.11 | 410.95% | Nicole Germino43% | → $21 | Initiates | → Buy | Get Alert |
05/29/2024 | INSM | Buy Now | Insmed | $72.64 | -6.39% | Nicole Germino43% | $48 → $68 | Maintains | Buy | Get Alert |
05/16/2024 | INSM | Buy Now | Insmed | $72.64 | -33.92% | Nicole Germino43% | $48 → $48 | Maintains | Buy | Get Alert |
04/23/2024 | INSM | Buy Now | Insmed | $72.64 | -33.92% | Nicole Germino43% | → $48 | Initiates | → Buy | Get Alert |
03/20/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Nicole Germino43% | $11 → $21 | Downgrade | Buy → Hold | Get Alert |
03/19/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Nicole Germino43% | $11 → $21 | Downgrade | Buy → Hold | Get Alert |
11/07/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.76 | — | Nicole Germino43% | — | Downgrade | Buy → Hold | Get Alert |
10/04/2023 | PNT | Buy Now | POINT Biopharma Global | — | — | Nicole Germino43% | $13 → $12.5 | Downgrade | Buy → Hold | Get Alert |
08/15/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.76 | 816.23% | Nicole Germino43% | $8 → $7 | Maintains | Buy | Get Alert |
05/10/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.76 | 947.12% | Nicole Germino43% | $16 → $8 | Maintains | Buy | Get Alert |
11/15/2022 | PNT | Buy Now | POINT Biopharma Global | — | — | Nicole Germino43% | $22 → $14 | Maintains | Buy | Get Alert |
10/24/2022 | ASMB | Buy Now | Assembly Biosciences | $9.80 | -79.59% | Nicole Germino43% | $132 → $24 | Downgrade | Buy → Hold | Get Alert |
09/16/2022 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Nicole Germino43% | → $10 | Initiates | → Buy | Get Alert |
09/16/2022 | PNT | Buy Now | POINT Biopharma Global | — | — | Nicole Germino43% | → $22 | Initiates | → Buy | Get Alert |
04/05/2022 | SGMO | Buy Now | Sangamo Therapeutics | $0.76 | 2386.91% | Nicole Germino43% | $23 → $19 | Maintains | Buy | Get Alert |
04/01/2022 | ASMB | Buy Now | Assembly Biosciences | $9.80 | 22.45% | Nicole Germino43% | $180 → $144 | Maintains | Buy | Get Alert |
09/03/2021 | FBRX | Buy Now | Forte Biosciences | $7.30 | — | Nicole Germino43% | — | Downgrade | Buy → Hold | Get Alert |
10/19/2020 | ASMB | Buy Now | Assembly Biosciences | $9.80 | 461.22% | Nicole Germino43% | → $660 | Initiates | → Buy | Get Alert |
08/25/2020 | FBRX | Buy Now | Forte Biosciences | $7.30 | 858.9% | Nicole Germino43% | → $1750 | Initiates | → Buy | Get Alert |